Taysha Gene Therapies Inc Live Stock Price Today, Share Analysis and Chart

Name: Taysha Gene Therapies Inc: Is Infosys Ltd. worth buying?
Item: Taysha Gene Therapies Inc
Rating: 1.11750
Author: Trendlyne DVM scores

about

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in deve...

4.49 -0.14 (-3.02%)

38.49% Fall from 52W High

5.0M

XNAS Volume

XNAS 05 Oct, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

7.0 / 100

Technically Neutral

37.7 / 100

1Yr Price target upside is 190%

13 analysts

Taysha Gene Therapies Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Taysha Gene Therapies Inc Live Stock Price Today, Share Analysis and Chart

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in deve...

38.49% Fall from 52W High

SWOT Analysis

Taysha Gene Therapies Inc Live Price Chart

Taysha Gene Therapies Inc Live Price Chart